Label: NEO-SYNEPHRINE HYDROCHLORIDE- phenylephrine hydrochloride injection, solution

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Export only

Drug Label Information

Updated January 13, 2021

If you are a consumer or patient please visit this version.

  • PRINCIPAL DISPLAY PANEL - 1 mL Ampule Label

    1 mL
    NDC 0409-1800-01

    Neo-Synephrine®
    HCl

    Rx only

    phenylephrine HCl
    injection, USP

    10 mg/mL

    1% Solution
    Hospira, Inc.
    Lake Forest, IL 60045 USA

    RL-1423 (11/05)

    PRINCIPAL DISPLAY PANEL - 1 mL Ampule Label
  • PRINCIPAL DISPLAY PANEL - 1 mL Ampule Cello Pack Label

    1 mL (10 mg)
    Single-dose
    5 Ampuls
    NDC 0409-1800-01

    Neo-Synephrine® HCl
    phenylephrine hydrochloride injection, USP
    1% Sterile Aqueous Injection

    FOR PARENTERAL USE
    Rx only

    PROTECT FROM LIGHT.

    Each mL contains 10 mg NEO-SYNEPHRINE hydrochloride,
    brand of phenylephrine hydrochloride, 3.5 mg sodium
    chloride, 4 mg sodium citrate, 1 mg citric acid monohydrate,
    and not more than 2 mg sodium metabisulfite as preservative.
    For usual dosage and route of administration, see package
    insert. Store at 20 to 25°C (68 to 77°F). [See USP Controlled
    Room Temperature.]
    WARNING: CONTAINS SULFITES.

    Printed in USA
    Hospira, Inc., Lake Forest, IL 60045 USA
    Hospira

    RL-2067 (3/07)

    PRINCIPAL DISPLAY PANEL - 1 mL Ampule Cello Pack Label
  • INGREDIENTS AND APPEARANCE
    NEO-SYNEPHRINE HYDROCHLORIDE 
    phenylephrine hydrochloride injection, solution
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0409-1800
    Route of AdministrationSUBCUTANEOUS, INTRAMUSCULAR, INTRAVENOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) PHENYLEPHRINE HYDROCHLORIDE10 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 3.5 mg  in 1 mL
    SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR) 4 mg  in 1 mL
    CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) 1 mg  in 1 mL
    SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0409-1800-015 in 1 CELLO PACK03/14/2006
    11 mL in 1 AMPULE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    EXPORT ONLY03/14/2006
    Labeler - Hospira, Inc. (141588017)
    Establishment
    NameAddressID/FEIBusiness Operations
    Hospira, Inc.093132819ANALYSIS(0409-1800) , LABEL(0409-1800) , MANUFACTURE(0409-1800) , PACK(0409-1800)